News | May 11, 2022
Aurobindo Pharma Ltd gets 6 observations from USFDA for Unit VII
The unit is an oral manufacturing facility at Jedcherla, Hyderabad
The unit is an oral manufacturing facility at Jedcherla, Hyderabad
Technology Development Board supports commercialisation of Metal Injection Molding of implants
It’s the company’s fourth manufacturing site worldwide. Others are located in the US, UK and China
Nureca Ltd has reported financial results for the period ended June 30, 2021.
The company posted net profit of Rs.594.6 crores for the period ended June 30, 2020.
The company has posted net profit of Rs. 283 crore for the 6 months period ended September 30, 2025
Tatva Chintan Pharma Chem has reported total income of Rs. 124.52 crore during the period ended September 30, 2025
It will produce a comprehensive range of dosage forms including tablets, hard gelatin capsules, liquids, injectables, topicals, and beta-lactam products
Mesalamine suppositories are indicated for the treatment of mildly to moderately active ulcerative proctitis
Bioconjugation capability to complement commercial payload, linker, and monoclonal antibody services
Subscribe To Our Newsletter & Stay Updated
